Skip to main content

and
  1. Article

    Open Access

    Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma

    A novel somatostatin analogue, TT-232 (which inhibits the proliferation of various cell cultures and transplantable mouse tumours), was examined regarding its effect on human melanoma and lymphoma xenografts a...

    B Szende, A Horváth, G Bökönyi, G Kéri in British Journal of Cancer (2003)

  2. Article

    Open Access

    Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

    Insulin-like growth factors (IGFs) I and II are implicated in progression of various tumours including colorectal carcinomas. To interfere with the production of IGFs, we treated male nude mice bearing xenogra...

    K Szepeshazi, A V Schally, K Groot, P Armatis, G Halmos in British Journal of Cancer (2000)

  3. No Access

    Article

    Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats

    The possible protective effect of an agonist of luteinising hormone-releasing hormone (LH-RH) against the ovarian damage caused by cyclophosphamide was investigated in rats. D-Trp6-LH-RH microcapsules were inj...

    L Bokser, B Szende, AV Schally in British Journal of Cancer (1990)

  4. No Access

    Article

    Studies on in vitro carcinogenesis

    The incorporation of radioactive labelled Methylcholanthrene into CBA/T6T6 mouse embryonic fibroblast cultures was studied by using light and electronmicroscopic autoradiographic and also liquid scintillation cou...

    L. Kopper, A. Jeney, G. Ferencz, K. Lapis in Zeitschrift für Krebsforschung und Klinisc… (1976)

  5. No Access

    Article

    A Transferable “Resistance Factor” from in vitro Cultured MDMS-Resistant Yoshida Sarcoma Cells

    Cells of the methylene dimethanesulphonate-(MDMS)-resistant Yoshida sarcoma cell line contain a low molecular weight “resistance factor” which is present in the culture medium of these cells and may be utilize...

    B Szende, M Fox, B W Fox in British Journal of Cancer (1973)

  6. No Access

    Article

    Über die geschwulsterzeugende Wirkung des Hydrazins

    Die Autoren haben 34 weißen Mäusen intraperitoneal insgesamt 400 mg/kg Körpergewicht Hydrazin verabreicht. Zwischen dem 100. und 313. Versuchstag entstanden bei 13 Tieren Reticulosarkome und Leukämien (s. Tabe...

    J. Juhász, J. Baló, B. Szende in Zeitschrift für Krebsforschung (1967)

  7. No Access

    Article

    Neue experimentelle Angaben zur geschwulsterzeugenden Wirkung des Isonicotinsäurehydrazid (INH)

    50 weißen Mäusen wurde Isonicotinsäurehydrazid in physiologischer Kochsalzlösung längere Zeit hindurch intraperitoneal in einer Gesamtmenge von 55 mg verabreicht. In 95–400 Tagen nach Versuchsbeginn traten bei...

    J. Juhász, J. Baló, B. Szende in Zeitschrift für Krebsforschung (1963)